ANALISIS COST-EFFECTIVENESS PENGGUNAAN SEFTRIAKSON DAN SEFOTAKSIM PADA TERAPI PROFILAKSIS APENDEKTOMI DI RS PKU MUHAMMADIYAH YOGYAKARTA TAHUN 2006-2007

Authors

  • Sri Aisyah Muhartati Fakultas Farmasi UAD
  • Muh Muhlis Fakultas Farmasi UAD
  • Woro Supadmi Fakultas Farmasi UAD

DOI:

https://doi.org/10.12928/pharmaciana.v1i2.527

Keywords:

Cost-effectiveness analysis ceftriaxone, cefotaxim, prophylactic antibiotics, appendectomy

Abstract

Cost-effectiveness analysis of ceftriaxone and cefotaxim prophylactic antibiotics
of appendectomy in PKU Muhammadiyah Hospital Yogyakarta from January 2006 to
December 2007 has been studied. This study was aimed to explore the direct medical
cost, cost-effectiveness ratio, and determine whether drugs of ceftriaxone or cefotaxim
whose had more effective cost. This study was carried out by descriptive retrospective
design. The population was all inpatients of appendectomy getting prophylaxis
antibiotics with either ceftriaxon or cefotaxim therapy in PKU Muhammadiyah
Hospital Yogyakarta. The population target were the appendectomy patients in the
third class of PKU Muhammadiyah Hospital Yogyakarta from January 2006 to
December 2007. The result indicated that direct medical cost of the patients getting
ceftriaxone therapy was Rp 422.257, whereas the cost of the patients getting cefotaxim
therapy was Rp 487.680. Cost-effectiveness ratio of whom getting ceftriaxone therapy
was Rp 105.564/day, whereas the ratio of whom getting cefotaxim therapy was Rp
162.560. Finally, it have not been able to determine which drug is more cost-effective.

Downloads

Published

2011-11-01

Issue

Vol. 1 No. 2 (2011): Pharmaciana

Section

Analytical Pharmacy and Medicinal Chemistry

License

Authors who publish with Pharmaciana agree to the following terms:

  1. Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.